ERASMUS MUNDUS MASTER'S DEGREE IN HUMAN DISEASES MODELS MORPHOLOGICAL PHENOTYPING (MORPHOPHEN)

I am a biochemist, computational biologist, and biomedical researcher currently pursuing the Erasmus Mundus Joint Master's Degree in Human Disease Models and Morphological Phenotyping (MorphoPHEN) through a consortium comprising Universitat Autònoma de Barcelona (Spain), University of Naples Federico II (Italy), Aristotle University of Thessaloniki (Greece), and the University of Lisbon (Portugal). My research integrates experimental and computational approaches to investigate human diseases, with particular emphasis on cancer biology, immunology, neurobiology, multi-omics analysis, and artificial intelligence-driven biomedical discovery. My scientific training spans translational cancer research, humanized mouse models, tumor immunology, spatial transcriptomics, computational drug discovery, molecular imaging, and systems biology. Through research appointments at institutions including Universitat Autònoma de Barcelona, CEINGE Biotecnologie Avanzate, Aga Khan University, LUMS, ICCBS, Nicolaus Copernicus University, Nanjing University, and Adam Mickiewicz University, I have contributed to projects involving immuno-oncology, biomarker discovery, neurodevelopmental modeling, liver cancer, melanoma immunotherapy, and precision medicine. My research interests focus on understanding disease mechanisms through the integration of genomics, transcriptomics, proteomics, metabolomics, imaging, and machine learning. I am particularly interested in leveraging artificial intelligence, computational modeling, and multi-omics technologies to identify novel therapeutic targets, improve disease diagnosis, and accelerate drug discovery. My work combines experimental biology with advanced bioinformatics approaches, including single-cell analysis, spatial biology, deep learning, systems immunology, and predictive modeling. In addition to research, I actively engage in scientific leadership, education, mentoring, and international collaboration. I have participated in numerous global conferences, advanced training programs, and interdisciplinary initiatives aimed at advancing biomedical sciences and improving human health. My long-term vision is to develop next-generation computational and biological platforms that enable precision medicine and transform the discovery of therapies for cancer, neurological disorders, and other complex diseases. Research Interests: Cancer Biology, Tumor Immunology, Computational Biology, Bioinformatics, Artificial Intelligence in Biomedicine, Precision Medicine, Drug Discovery, Systems Biology, Multi-Omics Integration, Single-Cell Genomics, Spatial Transcriptomics, Neurobiology, Translational Medicine, Human Disease Models, Molecular Imaging, Biomarker Discovery, Immunotherapy, and Machine Learning for Healthcare.